The past, present and future role of the dopamine D2 receptor in schizophrenia

被引：0
|
作者：
Kapur, S. [1 ]
机构：
[1] Kings Coll London, Psychosis Studies Inst Psychiat, London WC2R 2LS, England
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2010年 / 20卷
关键词：
D-2; ANTIPSYCHOTICS;
D O I：
10.1016/S0924-977X(10)70125-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S163 / S164
页数：2
相关论文
共 50 条
  • [21] Schizophrenia, "Just the Facts" 5. Treatment and prevention Past, present, and future
    Tandon, Rajiv
    Nasrallah, Henry A.
    Keshavan, Matcheri S.
    SCHIZOPHRENIA RESEARCH, 2010, 122 (1-3) : 1 - 23
  • [22] Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia:: I.: Adenosine agonists
    Dixon, DA
    Fenix, LA
    Kim, DM
    Raffa, RB
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (04) : 480 - 488
  • [23] Potent Dopamine D2 Antagonists Block the Reward-Enhancing Effects of Nicotine in Smokers With Schizophrenia
    Whitton, Alexis E.
    Green, Alan I.
    Pizzagalli, Diego A.
    Roth, Robert M.
    Williams, Jill M.
    Brunette, Mary F.
    SCHIZOPHRENIA BULLETIN, 2019, 45 (06) : 1300 - 1308
  • [24] Extrapyramidal side-effects and dopamine D2/3 receptor binding in substantia nigra
    Tuppurainen, Heli
    Kuikka, Jyrki T.
    Viinamaki, Heimo
    Husso, Minna
    Tiihonen, Jari
    NORDIC JOURNAL OF PSYCHIATRY, 2010, 64 (04) : 233 - 238
  • [25] The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats
    Turrone, P
    Remington, G
    Kapur, S
    Nobrega, JN
    PSYCHOPHARMACOLOGY, 2003, 165 (02) : 166 - 171
  • [26] Antipsychotic-induced alterations in D2 dopamine receptor interacting proteins within the cortex
    Kabbani, N
    Levenson, R
    NEUROREPORT, 2006, 17 (03) : 299 - 301
  • [27] Structure-Based Virtual Screening for Dopamine D2 Receptor Ligands as Potential Antipsychotics
    Kaczor, Agnieszka A.
    Silva, Andrea G.
    Loza, Maria I.
    Kolb, Peter
    Castro, Marian
    Poso, Antti
    CHEMMEDCHEM, 2016, 11 (07) : 718 - 729
  • [28] Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents
    Calarge, Chadi A.
    Ellingrod, Vicki L.
    Acion, Laura
    Miller, Del D.
    Moline, Jessica
    Tansey, Michael J.
    Schlechte, Janet A.
    PHARMACOGENETICS AND GENOMICS, 2009, 19 (05): : 373 - 382
  • [29] Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase
    Lee, KW
    Hong, JH
    Choi, IY
    Che, YZ
    Lee, JK
    Yang, SD
    Song, CW
    Kang, HS
    Lee, JH
    Noh, JS
    Shin, HS
    Han, PL
    JOURNAL OF NEUROSCIENCE, 2002, 22 (18): : 7931 - 7940
  • [30] Clozapine, atypical antipsychotics, and the benefits of fast-off D2 dopamine receptor antagonism
    Georges Vauquelin
    Sophie Bostoen
    Patrick Vanderheyden
    Philip Seeman
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2012, 385 : 337 - 372
12345